Co-Diagnostics Expands Vector Smart Mosquito Surveillance to 21 States — Co-Diagnostics, Inc. (Co-Dx)

Event summary

Co-Diagnostics' Vector Smart division now serves mosquito abatement districts in 21 states, adding four new full laboratory installs in June 2026.
The expansion coincides with a webinar for prospective customers during National Mosquito Control Awareness Week.
Vector Smart offers multiplex PCR tests for diseases including West Nile, Zika, and dengue to decentralize mosquito pool testing.
CEO Dwight Egan highlights the growing urgency around vector-borne disease surveillance as a driver of adoption.

The big picture

Co-Diagnostics' expansion reflects growing demand for localized vector-borne disease monitoring as mosquito-related illnesses cause over 700,000 deaths annually. The company positions itself as a leader in decentralized PCR testing, which could become critical as climate change expands mosquito habitats and disease ranges. This strategic move aligns with increasing public health focus on proactive surveillance systems.

What we're watching

Market Adoption Pace: Whether Co-Diagnostics can sustain its rapid customer acquisition in mosquito abatement districts.
Regulatory Dynamics: How decentralized PCR testing regulations may evolve to support or restrict Vector Smart's growth.
Competitive Positioning: The pace at which competitors develop similar mosquito surveillance technologies.